Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The market trades near all-time highs with extreme valuations, driven by passive investing and questionable underlying ...

In 2015, AI in drug discovery was still a theoretical pursuit – exciting, but unproven. A few early start-ups were applying deep learning to virtual screening and molecular modelling, but the industry ...

One of the best things about investing and trading in 2026 is that even the average retail trader has access to an unprecedented amount of data and analytical tools. Unfortunately, many of those ...